Panacea Biotec Shareholding Pattern
- Market cap
- ₹2,122 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹249.48 – ₹467.78
As of Jun 2026, promoters held 48.50% of Panacea Biotec, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Panacea Biotec shareholding pattern — frequently asked questions
What is the promoter holding in Panacea Biotec?
Promoters held 48.50% of Panacea Biotec as of Jun 2026.
How much do FIIs hold in Panacea Biotec?
Foreign institutional investors held 18.40% of Panacea Biotec as of Jun 2026.
How much do domestic institutions hold in Panacea Biotec?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Panacea Biotec as of Jun 2026; mutual funds alone held 8.50%.
Who owns Panacea Biotec?
As of Jun 2026, Panacea Biotec's shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
Trade Panacea Biotec With ATS
Track PANACEABIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.